Lactose (India) Ltd | 141 Cr. | 100 | 247/84.3 | 27.3 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.48 Cr. | 2.87 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 41.4 Cr. | 55.8 | 94.9/44.5 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 37.7 Cr. | 25.7 | 29.1/13.1 | 37.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 70.6 Cr. | 93.8 | 155/79.0 | 16.1 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 48,345 Cr. | 1,713 | 1,831/1,199 | 36.7 | 314 | 0.15 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 285 Cr. | 12.5 | 29.0/11.2 | 17.7 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 384 Cr. | 813 | 904/635 | 18.4 | 299 | 0.08 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 99.5 Cr. | 19.9 | 32.0/14.6 | 33.7 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 898 Cr. | 305 | 449/163 | 11.8 | 123 | 0.41 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 6.62 Cr. | 31.5 | 39.0/22.8 | 50.9 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 13.3 Cr. | 5.35 | 12.3/2.11 | 148 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 350 Cr. | 361 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,973 Cr. | 1,143 | 1,584/1,030 | 52.4 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 199 Cr. | 1.07 | 1.37/0.53 | 26.4 | 1.12 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 54.0 Cr. | 22.4 | 26.3/6.40 | 65.0 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 10.9 Cr. | 10.8 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 206 Cr. | 576 | 999/567 | 8.32 | 563 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 31.5 Cr. | 31.5 | 45.0/26.1 | 105 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 21.6 Cr. | 47.2 | 88.7/40.2 | 43.2 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.5 Cr. | 4.20 | 26.2/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.6 Cr. | 118 | 154/55.1 | 51.9 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 13.9 Cr. | 25.4 | 28.9/6.08 | 463 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 43.8 Cr. | 58.0 | 85.5/46.2 | 50.9 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.02 Cr. | 16.7 | 27.5/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,300 Cr. | 882 | 986/390 | 50.1 | 65.3 | 0.12 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 104 Cr. | 24.1 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.34 Cr. | 18.4 | 46.0/17.4 | 16.1 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 153 Cr. | 265 | 418/241 | 16.5 | 119 | 1.69 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 22.2 Cr. | 37.7 | 62.6/14.8 | 55.5 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 65,631 Cr. | 1,120 | 1,593/994 | 18.9 | 557 | 0.40 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 168 Cr. | 270 | 300/156 | 91.5 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,049 Cr. | 209 | 250/148 | 22.2 | 65.1 | 1.20 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 36.1 Cr. | 27.7 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.62 Cr. | 0.85 | 1.45/0.62 | 562 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 272 Cr. | 35.5 | 77.7/34.1 | 27.2 | 18.3 | 0.00 % | 8.60 % | 7.23 % | 10.0 |
Adline Chem Lab Ltd | 11.2 Cr. | 19.1 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 83.6 Cr. | 3.55 | 6.25/2.82 | 152 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 67,344 Cr. | 31,667 | 32,229/25,260 | 47.6 | 1,992 | 1.50 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,846 Cr. | 866 | 950/521 | 28.8 | 220 | 0.35 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 184 Cr. | 64.6 | 75.8/31.3 | 45.9 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 2,810 Cr. | 955 | 1,078/535 | | 78.1 | 0.10 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 27,875 Cr. | 1,716 | 1,870/630 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 918 Cr. | 280 | 330/151 | 30.1 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 587 Cr. | 439 | 477/270 | 15.0 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,209 Cr. | 600 | 950/510 | 30.6 | 348 | 0.00 % | 6.36 % | 5.71 % | 2.00 |
TTK Healthcare Ltd | 1,815 Cr. | 1,284 | 1,923/991 | 25.5 | 754 | 0.78 % | 9.25 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,09,323 Cr. | 3,227 | 3,591/2,755 | 56.7 | 224 | 0.99 % | 27.2 % | 26.7 % | 5.00 |
Themis Medicare Ltd | 1,216 Cr. | 132 | 317/115 | 40.8 | 43.7 | 0.38 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,825 Cr. | 19.4 | 27.9/12.3 | 37.4 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,167 Cr. | 237 | 272/99.1 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,00,689 Cr. | 1,670 | 1,960/1,495 | 34.9 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,820 Cr. | 635 | 886/441 | 5,221 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,125 Cr. | 239 | 398/175 | 31.1 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 365 Cr. | 1,203 | 1,750/765 | 19.5 | 650 | 0.12 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,359 Cr. | 857 | 1,003/530 | 93.4 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,856 Cr. | 194 | 241/111 | 219 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 14,209 Cr. | 6,170 | 7,600/4,146 | 37.4 | 374 | 1.88 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 4,012 Cr. | 2,426 | 2,977/1,540 | 34.0 | 321 | 0.83 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 9,782 Cr. | 5,893 | 6,176/4,863 | 37.6 | 323 | 1.36 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 208 Cr. | 59.0 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,802 Cr. | 5,640 | 6,453/3,701 | 40.3 | 922 | 0.63 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 118 Cr. | 95.6 | 348/81.0 | 8.81 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,487 Cr. | 406 | 582/130 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,555 Cr. | 700 | 1,998/604 | 35.7 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 15,693 Cr. | 12,249 | 18,100/6,755 | 77.4 | 1,188 | 0.10 % | 18.2 % | 14.4 % | 10.0 |
Nectar Lifescience Ltd | 473 Cr. | 21.1 | 56.5/20.0 | 27.8 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,592 Cr. | 869 | 1,639/660 | 8.28 | 425 | 1.09 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,392 Cr. | 61.9 | 101/41.7 | 28.7 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 10,994 Cr. | 243 | 359/158 | 28.9 | 54.4 | 0.25 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 126 Cr. | 79.8 | 145/70.1 | 18.3 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 405 Cr. | 114 | 177/90.2 | 51.1 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 88,138 Cr. | 1,931 | 2,403/1,545 | 26.9 | 377 | 0.41 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,119 Cr. | 558 | 980/499 | 13.6 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 36,089 Cr. | 670 | 685/390 | 106 | 84.6 | 0.18 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,067 Cr. | 1,028 | 1,140/481 | 26.7 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 192 Cr. | 87.9 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 862 Cr. | 179 | 370/155 | 22.4 | 107 | 1.68 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 676 Cr. | 419 | 500/271 | 27.1 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 17,842 Cr. | 1,120 | 1,310/701 | 32.2 | 393 | 0.45 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 28,054 Cr. | 1,799 | 2,030/1,303 | 42.5 | 221 | 0.68 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,442 Cr. | 217 | 328/126 | 36.3 | 36.1 | 0.92 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,852 Cr. | 1,334 | 1,758/1,052 | 39.0 | 274 | 0.30 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,712 Cr. | 92.4 | 108/57.5 | 26.8 | 57.5 | 1.08 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 87.3 Cr. | 16.0 | 34.7/12.0 | 1.36 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 664 Cr. | 109 | 186/67.2 | 8.02 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,640 Cr. | 285 | 388/190 | | 111 | 0.53 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,526 Cr. | 367 | 465/309 | 49.8 | 102 | 0.33 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,538 Cr. | 1,805 | 3,379/1,243 | 55.9 | 369 | 0.33 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,502 Cr. | 350 | 504/285 | 50.1 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,865 Cr. | 489 | 725/412 | 24.8 | 153 | 0.31 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 47,461 Cr. | 1,683 | 1,831/1,199 | 36.0 | 314 | 0.15 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 54,739 Cr. | 3,229 | 3,516/1,921 | 62.6 | 115 | 1.30 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 29,088 Cr. | 1,765 | 2,221/1,200 | 26.7 | 592 | 1.13 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 7,781 Cr. | 478 | 659/359 | 29.2 | 140 | 1.05 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 21,845 Cr. | 1,604 | 1,910/987 | 62.1 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,11,624 Cr. | 1,337 | 1,421/1,020 | 19.7 | 402 | 0.60 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,802 Cr. | 243 | 308/155 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,21,411 Cr. | 1,502 | 1,702/1,310 | 23.0 | 386 | 0.87 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 15,629 Cr. | 2,056 | 2,641/1,365 | 29.1 | 375 | 0.24 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 433 Cr. | 145 | 203/82.0 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,573 Cr. | 149 | 186/101 | 18.6 | 99.7 | 0.34 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 75.4 Cr. | 46.0 | 92.0/40.4 | 135 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 41,937 Cr. | 349 | 405/291 | 43.6 | 180 | 0.14 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,802 Cr. | 1,785 | 2,215/1,122 | 39.4 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 157 Cr. | 98.6 | 158/76.3 | 21.7 | 48.6 | 1.22 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 183 Cr. | 76.9 | 96.0/67.8 | 29.1 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,931 Cr. | 8,778 | 10,691/6,070 | 125 | 308 | 0.27 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,081 Cr. | 720 | 863/544 | 40.9 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 209 Cr. | 99.1 | 145/82.2 | 10.6 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 57,481 Cr. | 4,811 | 6,440/4,492 | 26.5 | 1,002 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,625 Cr. | 947 | 1,304/725 | 32.8 | 264 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 481 Cr. | 843 | 1,754/763 | 27.9 | 688 | 0.59 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 32,080 Cr. | 2,564 | 3,486/2,022 | 35.0 | 303 | 1.40 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,675 Cr. | 329 | 571/258 | 28.0 | 127 | 1.58 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,032 Cr. | 438 | 635/312 | 25.6 | 136 | 0.23 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,655.21 Cr | 1,158.10 | | 102.89 | 194.82 | 0.31% | 16.66% | 15.19% | 6.18 |